Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
At NINGBO INNO PHARMCHEM CO.,LTD., our mission is to advance healthcare through cutting-edge pharmaceutical solutions. We are particularly focused on developing targeted therapies for complex diseases like cancer. Our current research highlights the significant potential of SN38-glucose conjugates as a novel approach to cancer treatment, especially for challenging conditions such as colorectal cancer.
The core of our innovation lies in understanding and exploiting the metabolic differences between cancer cells and normal cells. Cancer cells often exhibit increased glucose consumption and uptake, a phenomenon that our SN38-glucose conjugates are designed to harness. By chemically linking the potent anticancer agent SN38 to glucose, we create a sophisticated delivery system that preferentially enters cancer cells via glucose transporters. This strategy is a prime example of effective glucose transporter targeted drug delivery.
Our scientific team at NINGBO INNO PHARMCHEM CO.,LTD. has synthesized a series of these SN38-glucose conjugates, with one promising candidate, compound 5b, showing remarkable results in preclinical studies. This compound exhibits strong cytotoxic effects against colorectal cancer cell lines and has demonstrated significant antitumor activity in vivo. The ability of 5b to induce apoptosis and inhibit cell migration are key indicators of its therapeutic promise. These findings underscore the effectiveness of our novel SN38 glucose conjugates targeting cancer cells.
The development of novel anticancer agents for CRC treatment is a critical area of research, and our work with SN38-glucose conjugates represents a significant advancement. By improving the selectivity and potency of chemotherapy, we aim to offer patients more effective treatment options with fewer adverse effects. This focus on selective chemotherapy for colorectal cancer is central to our R&D strategy.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing high-quality pharmaceutical intermediates and active pharmaceutical ingredients that support groundbreaking research. We believe that by leveraging advanced chemical synthesis and targeted delivery strategies, we can contribute significantly to the development of next-generation cancer therapies. Our commitment to innovation extends to all aspects of our operations, from synthesis to quality control.
We invite researchers and pharmaceutical companies to collaborate with NINGBO INNO PHARMCHEM CO.,LTD. to explore the therapeutic potential of these advanced SN38-glucose conjugates. By working together, we can accelerate the development of life-saving treatments and make a tangible impact on the lives of cancer patients worldwide. Our ongoing efforts in preclinical oncology drug development are a testament to our dedication to fighting cancer.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
